QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration
QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration is a PHASE1 clinical asset sponsored by Fuzhou General Hospital in NSCLC. SEO and diligence focus: QYJD Compound Preparation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: NSCLC
Modality: small molecule
Target: QYJD Compound Preparation
Sponsor: Fuzhou General Hospital
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 22, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: QYJD Compound Preparation
View original source fields
Condition raw: NSCLC
Condition normalized: NSCLC
Modality raw: small molecule
Modality normalized: small molecule
Target raw: QYJD Compound Preparation
Target normalized: QYJD Compound Preparation